METASTATIC TRIPLE NEGATIVE BREAST CANCERS

Clinical trials for METASTATIC TRIPLE NEGATIVE BREAST CANCERS explained in plain language.

Never miss a new study

Get alerted when new METASTATIC TRIPLE NEGATIVE BREAST CANCERS trials appear

Sign up with your email to follow new studies for METASTATIC TRIPLE NEGATIVE BREAST CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New hope for Tough-to-Treat breast cancer

Disease control Ongoing

This study is testing a new drug called BNT327, given alongside standard chemotherapy, for people with advanced triple-negative breast cancer. The main goals are to see if the combination is safe and if it helps shrink tumors. The trial will enroll about 83 adults who have either…

Matched conditions: METASTATIC TRIPLE NEGATIVE BREAST CANCERS

Phase: PHASE2 • Sponsor: BioNTech SE • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

METASTATIC TRIPLE NEGATIVE BREAST CANCERS

Get alerted when new METASTATIC TRIPLE NEGATIVE BREAST CANCERS trials appear

New hope for Tough-to-Treat breast cancer